Citi Opens 30-Day Upside Catalyst Watch on Beam Therapeutics Inc. (BEAM)

Go back to Citi Opens 30-Day Upside Catalyst Watch on Beam Therapeutics Inc. (BEAM)

Cantor Fitzgerald Downgrades Beam Therapeutics Inc (BEAM) to Neutral

October 20, 2023 3:31 PM EDT

Cantor Fitzgerald analyst Rick Bienkowski downgraded Beam Therapeutics Inc (NASDAQ: BEAM) from Overweight to Neutral.


For an analyst ratings summary and ratings history on Beam Therapeutics Inc click here. For more ratings news on Beam Therapeutics Inc click here.


Shares of Beam Therapeutics Inc closed at $18.36 yesterday.

... More

Beam Therapeutics Inc (BEAM) PT Lowered to $75 at Wells Fargo

October 20, 2023 8:16 AM EDT

Wells Fargo lowered its price target on Beam Therapeutics Inc (NASDAQ: BEAM) to $75.00 (from $105.00) while maintaining a Overweight rating.... More

Leerink Partners Downgrades Beam Therapeutics Inc (BEAM) to Market Perform

October 20, 2023 6:06 AM EDT

Leerink Partners analyst Rick Bienkowski downgraded Beam Therapeutics Inc (NASDAQ: BEAM) from Outperform to Market Perform.


For an analyst ratings summary and ratings history on Beam Therapeutics Inc click here. For more ratings news on Beam Therapeutics Inc click here.


Shares of Beam Therapeutics Inc closed at $18.36 yesterday.

... More